Xiaolin Wang files SEC Form 4 disclosures for Revolution Medicines, Inc.. They have made 8 open-market trades across 1 company since 2021, most recently 2026-03-17.
CIK 0001849181
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 116,063 | $23.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-03-17 | 2026-03-19 | $99.48 | $400K | -0.7% | +49.3% | +61.1% |
| RVMD | SELL | 2023-03-17 | 2023-03-21 | $21.78 | $16K | +1.9% | +15.0% | +20.8% |
| RVMD | SELL | 2022-12-19 | 2022-12-21 | $22.94 | $16K | -1.8% | +15.9% | -10.0% |
| RVMD | SELL | 2022-09-19 | 2022-09-21 | $19.04 | $14K | +14.3% | +8.8% | +29.7% |
| RVMD | SELL | 2022-06-17 | 2022-06-22 | $17.75 | $12K | +27.1% | +22.3% | +6.8% |
| RVMD | SELL | 2022-03-17 | 2022-03-21 | $18.61 | $4K | +16.4% | +7.7% | -17.0% |
| RVMD | SELL | 2021-12-17 | 2021-12-21 | $24.41 | $6K | +2.6% | -8.7% | -18.6% |
| RVMD | SELL | 2021-09-17 | 2021-09-21 | $30.02 | $8K | -8.9% | -14.5% | -19.2% |
| RVMD | SELL | 2021-06-17 | 2021-06-22 | $34.12 | $8K | -0.3% | -12.7% | -6.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.